Literature DB >> 19726606

Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases.

Hiroaki Ogiwara1, Mitsushige Sugimoto, Tomoyuki Ohno, Ratha-Korn Vilaichone, Varocha Mahachai, David Y Graham, Yoshio Yamaoka.   

Abstract

The vacuolating cytotoxin gene of Helicobacter pylori, vacA, induces cytoplasmic vacuolation in gastric epithelial cells. Recently, the vacA intermediate (i) region, which is located between the signal (s) and middle (m) regions, was identified as a third polymorphic determinant of vacA activity. In vacA, there are approximately 81-bp deletions between the vacA i and m regions (denoted the d region). The aim was to clarify the roles of the vacA d region in relation to H. pylori-related diseases and histopathological gastric mucosal changes. We assessed the vacA signal s-, m-, i-, and d-region genotypes and cagA status in H. pylori isolates recovered from Western countries (n = 266) and East Asian countries (n = 244) by PCR. In East Asian countries, there were no relationships between the vacA genotypes and the clinical outcomes and histopathological changes. In Western countries, strains with the vacA s1, m1, i1, or d1 (no deletion) genotype significantly increased the risk for the development of gastric cancer compared with the risk from strains with the s2, m2, i2, or d2 genotype (adjusted odd ratios, 3.17 [95% confidence interval {CI}, 1.07 to 9.45] for s1, 10.65 [95% CI, 3.36 to 31.35] for m1, 8.57 [95% CI, 2.85 to 25.81] for i1, and 8.04 [95% CI, 2.67 to 24.16] for d1). The highly virulent vacA genotypes significantly enhanced neutrophil infiltration and gastric atrophy in univariant analysis, whereas only the vacA d-region genotype was significantly associated with neutrophil infiltration and gastric atrophy in both the antrum and the corpus by multiple linear regression analysis. The presence of the vacA d1 genotype in H. pylori strains could be an improved predictor of histological inflammation and the potential for atrophy compared with the presence of the vacA s-, m-, and i-region genotypes in Western countries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726606      PMCID: PMC2772588          DOI: 10.1128/JCM.00887-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity.

Authors:  D P Letley; J C Atherton
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  Expression and binding analysis of GST-VacA fusions reveals that the C-terminal approximately 100-residue segment of exotoxin is crucial for binding in HeLa cells.

Authors:  H J Wang; W C Wang
Journal:  Biochem Biophys Res Commun       Date:  2000-11-19       Impact factor: 3.575

3.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

4.  A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.

Authors:  A D Vinion-Dubiel; M S McClain; D M Czajkowsky; H Iwamoto; D Ye; P Cao; W Schraw; G Szabo; S R Blanke; Z Shao; T L Cover
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

5.  Interactions between p-33 and p-55 domains of the Helicobacter pylori vacuolating cytotoxin (VacA).

Authors:  Victor J Torres; Mark S McClain; Timothy L Cover
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

6.  Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms.

Authors:  Emad M El-Omar; Charles S Rabkin; Marilie D Gammon; Thomas L Vaughan; Harvey A Risch; Janet B Schoenberg; Janet L Stanford; Susan T Mayne; James Goedert; William J Blot; Joseph F Fraumeni; Wong-Ho Chow
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

7.  Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome.

Authors:  Y Yamaoka; T Kodama; M Kita; J Imanishi; K Kashima; D Y Graham
Journal:  Helicobacter       Date:  1998-12       Impact factor: 5.753

8.  Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms.

Authors:  Daniela Basso; Carlo-Federico Zambon; Darren P Letley; Alessia Stranges; Alberto Marchet; Joanne L Rhead; Stefania Schiavon; Graziella Guariso; Marco Ceroti; Donato Nitti; Massimo Rugge; Mario Plebani; John C Atherton
Journal:  Gastroenterology       Date:  2008-03-25       Impact factor: 22.682

9.  Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.

Authors:  Shioto Suzuki; Youko Muroishi; Isao Nakanishi; Yoshio Oda
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

10.  Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham; A R Sepulveda
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more
  36 in total

1.  Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan.

Authors:  Osamu Matsunari; Seiji Shiota; Rumiko Suzuki; Masahide Watada; Nagisa Kinjo; Kazunari Murakami; Toshio Fujioka; Fukunori Kinjo; Yoshio Yamaoka
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

2.  A Helicobacter pylori Vacuolating Cytotoxin A: Mouse DHFR Fusion Protein Triggers Dye Release from Liposomes.

Authors:  Aung Khine Linn; Nitchakan Samainukul; Somsri Sakdee; Chanan Angsuthanasombat; Gerd Katzenmeier
Journal:  Curr Microbiol       Date:  2017-10-14       Impact factor: 2.188

Review 3.  Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori.

Authors:  Rumiko Suzuki; Seiji Shiota; Yoshio Yamaoka
Journal:  Infect Genet Evol       Date:  2011-12-17       Impact factor: 3.342

Review 4.  Mechanisms of disease: Helicobacter pylori virulence factors.

Authors:  Yoshio Yamaoka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-12       Impact factor: 46.802

5.  A novel method for genotyping the Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens.

Authors:  Rui M Ferreira; Jose C Machado; Darren Letley; John C Atherton; Maria L Pardo; Carlos A Gonzalez; Fatima Carneiro; Ceu Figueiredo
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

Review 6.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

7.  Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants.

Authors:  Rhonda R Caston; Johanna C Sierra; Nora J Foegeding; Mandy D Truelock; Anne M Campbell; Arwen E Frick-Cheng; Diane Bimczok; Keith T Wilson; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

Review 8.  The significance of virulence factors in Helicobacter pylori.

Authors:  Seiji Shiota; Rumiko Suzuki; Yoshio Yamaoka
Journal:  J Dig Dis       Date:  2013-07       Impact factor: 2.325

Review 9.  Helicobacter pylori virulence and cancer pathogenesis.

Authors:  Yoshio Yamaoka; David Y Graham
Journal:  Future Oncol       Date:  2014-06       Impact factor: 3.404

Review 10.  Helicobacter pylori infection: new pathogenetic and clinical aspects.

Authors:  Krisztina Hagymási; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.